TG THERAPEUTICS, INC. Research and Development Expense
TG THERAPEUTICS, INC. (TGTX) reported Research and Development Expense of $95.34 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-05
- TG THERAPEUTICS, INC. research and development expense for the quarter ending 2026-06-30 was $95.34M, a 199.97% increase year-over-year.
- TG THERAPEUTICS, INC. research and development expense for the quarter ending 2026-03-31 was $48.40M, a 4.39% increase year-over-year.
- TG THERAPEUTICS, INC. research and development expense for the quarter ending 2025-12-31 was $41.19M, a 72.54% increase year-over-year.
- TG THERAPEUTICS, INC. research and development expense for the quarter ending 2025-09-30 was $40.88M, a 102.99% increase year-over-year.
- TG THERAPEUTICS, INC. research and development expense for fiscal 2025 was $160.22M, a 69.92% increase from fiscal 2024.
- TG THERAPEUTICS, INC. research and development expense for fiscal 2024 was $94.29M, a 23.75% increase from fiscal 2023.
- TG THERAPEUTICS, INC. research and development expense for fiscal 2023 was $76.19M, a 39.22% decline from fiscal 2022.
- TG THERAPEUTICS, INC. research and development expense for fiscal 2022 was $125.35M, a 43.68% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 13 month | Research and Development Expense 15 month | Research and Development Expense 16 month | Research and Development Expense 18 month | Research and Development Expense 19 month | Research and Development Expense 22 month | Research and Development Expense 25 month | Research and Development Expense 28 month | Research and Development Expense 119 month | Research and Development Expense 122 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $95.34M 10-Q · filed 2026-08-05 | $143.73M 10-Q · filed 2026-08-05 | $184.93M derived: sum of 3 quarters · filed 2026-08-05 | $225.80M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||
| 2026-03-31 | $48.40M 10-Q · filed 2026-05-06 | $89.59M derived: sum of 2 quarters · filed 2026-05-06 | $130.47M derived: sum of 3 quarters · filed 2026-05-06 | $162.25M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||
| 2025-12-31 | $41.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $82.07M derived: sum of 2 quarters · filed 2026-02-27 | $113.85M derived: sum of 3 quarters · filed 2026-08-05 | $160.22M 10-K · filed 2026-02-27 | ||||||||||||||
| 2025-09-30 | $40.88M 10-Q · filed 2025-11-05 | $72.66M derived: sum of 2 quarters · filed 2026-08-05 | $119.02M 10-Q · filed 2025-11-05 | $142.90M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||
| 2025-06-30 | $31.78M 10-Q · filed 2026-08-05 | $78.14M 10-Q · filed 2026-08-05 | $102.02M derived: sum of 3 quarters · filed 2026-08-05 | $122.16M derived: sum of 4 quarters · filed 2026-08-05 | ||||||||||||||
| 2025-03-31 | $46.36M 10-Q · filed 2026-05-06 | $70.24M derived: sum of 2 quarters · filed 2026-05-06 | $90.37M derived: sum of 3 quarters · filed 2026-05-06 | $107.93M derived: sum of 4 quarters · filed 2026-05-06 | ||||||||||||||
| 2024-12-31 | $23.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $44.01M derived: sum of 2 quarters · filed 2026-02-27 | $61.57M derived: sum of 3 quarters · filed 2026-02-27 | $94.29M 10-K · filed 2026-02-27 | ||||||||||||||
| 2024-09-30 | $20.14M 10-Q · filed 2025-11-05 | $37.69M derived: sum of 2 quarters · filed 2025-11-05 | $70.42M 10-Q · filed 2025-11-05 | $87.86M derived: sum of 4 quarters · filed 2026-02-27 | ||||||||||||||
| 2024-06-30 | $17.56M 10-Q · filed 2025-08-08 | $50.28M 10-Q · filed 2025-08-08 | $67.73M derived: sum of 3 quarters · filed 2026-02-27 | $82.48M derived: sum of 4 quarters · filed 2026-02-27 | ||||||||||||||
| 2024-03-31 | $32.72M 10-Q · filed 2025-05-09 | $50.17M derived: sum of 2 quarters · filed 2026-02-27 | $64.92M derived: sum of 3 quarters · filed 2026-02-27 | $93.05M derived: sum of 4 quarters · filed 2026-02-27 | ||||||||||||||
| 2023-12-31 | $17.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $32.20M derived: sum of 2 quarters · filed 2026-02-27 | $60.32M derived: sum of 3 quarters · filed 2026-02-27 | $76.19M 10-K · filed 2026-02-27 | ||||||||||||||
| 2023-09-30 | $14.75M 10-Q · filed 2024-11-07 | $42.88M derived: sum of 2 quarters · filed 2024-11-07 | $58.74M 10-Q · filed 2024-11-07 | $88.38M derived: sum of 4 quarters · filed 2025-03-03 | ||||||||||||||
| 2023-06-30 | $28.12M 10-Q · filed 2024-08-09 | $43.99M 10-Q · filed 2024-08-09 | $73.63M derived: sum of 3 quarters · filed 2025-03-03 | $94.43M derived: sum of 4 quarters · filed 2025-03-03 | ||||||||||||||
| 2023-03-31 | $15.87M 10-Q · filed 2024-05-06 | $45.51M derived: sum of 2 quarters · filed 2025-03-03 | $66.31M derived: sum of 3 quarters · filed 2025-03-03 | $93.18M derived: sum of 4 quarters · filed 2025-03-03 | ||||||||||||||
| 2022-12-31 | $29.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $50.44M derived: sum of 2 quarters · filed 2025-03-03 | $77.31M derived: sum of 3 quarters · filed 2025-03-03 | $125.35M 10-K · filed 2025-03-03 | ||||||||||||||
| 2022-09-30 | $20.80M 10-Q · filed 2023-11-06 | $47.67M derived: sum of 2 quarters · filed 2023-11-06 | $95.72M 10-Q · filed 2023-11-06 | $158.36M derived: sum of 4 quarters · filed 2024-02-29 | ||||||||||||||
| 2022-06-30 | $26.87M 10-Q · filed 2023-08-04 | $74.92M 10-Q · filed 2023-08-04 | $137.56M derived: sum of 3 quarters · filed 2024-02-29 | $189.53M derived: sum of 4 quarters · filed 2024-02-29 | ||||||||||||||
| 2022-03-31 | $48.04M 10-Q · filed 2023-05-08 | $110.69M derived: sum of 2 quarters · filed 2024-02-29 | $162.66M derived: sum of 3 quarters · filed 2024-02-29 | $207.53M derived: sum of 4 quarters · filed 2024-02-29 | ||||||||||||||
| 2021-12-31 | $62.65M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $114.61M derived: sum of 2 quarters · filed 2024-02-29 | $159.48M derived: sum of 3 quarters · filed 2024-02-29 | $222.58M 10-K · filed 2024-02-29 | ||||||||||||||
| 2021-09-30 | $51.97M 10-Q · filed 2022-11-09 | $96.84M derived: sum of 2 quarters · filed 2022-11-09 | $159.93M 10-Q · filed 2022-11-09 | $202.89M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||||||
| 2021-06-30 | $44.87M 10-Q · filed 2022-08-09 | $107.97M 10-Q · filed 2022-08-09 | $150.93M derived: sum of 3 quarters · filed 2023-03-01 | $201.39M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||||||
| 2021-03-31 | $63.09M 10-Q · filed 2022-05-10 | $106.06M derived: sum of 2 quarters · filed 2023-03-01 | $156.52M derived: sum of 3 quarters · filed 2023-03-01 | $192.97M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||||||
| 2020-12-31 | $42.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $93.42M derived: sum of 2 quarters · filed 2023-03-01 | $129.87M derived: sum of 3 quarters · filed 2023-03-01 | $165.90M 10-K · filed 2023-03-01 | ||||||||||||||
| 2020-09-30 | $50.46M 10-Q · filed 2021-11-08 | $86.91M derived: sum of 2 quarters · filed 2021-11-08 | $122.94M 10-Q · filed 2021-11-08 | $153.88M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||||||||
| 2020-06-30 | $36.45M 10-Q · filed 2021-08-06 | $72.47M 10-Q · filed 2021-08-06 | $103.41M derived: sum of 3 quarters · filed 2022-03-01 | $161.40M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||||||||
| 2020-03-31 | $36.02M 10-Q · filed 2021-05-10 | $66.97M derived: sum of 2 quarters · filed 2022-03-01 | $124.95M derived: sum of 3 quarters · filed 2022-03-01 | $157.82M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||||||||
| 2019-12-31 | $30.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $88.93M derived: sum of 2 quarters · filed 2022-03-01 | $121.79M derived: sum of 3 quarters · filed 2022-03-01 | $154.18M 10-K · filed 2022-03-01 | ||||||||||||||
| 2019-09-30 | $57.98M 10-Q · filed 2020-11-09 | $90.85M derived: sum of 2 quarters · filed 2020-11-09 | $123.24M 10-Q · filed 2020-11-09 | $175.51M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||||
| 2019-06-30 | $32.87M 10-Q · filed 2020-08-10 | $65.25M 10-Q · filed 2020-08-10 | $117.53M derived: sum of 3 quarters · filed 2021-03-01 | $150.93M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||||
| 2019-03-31 | $32.38M 10-Q · filed 2020-05-11 | $84.66M derived: sum of 2 quarters · filed 2021-03-01 | $118.06M derived: sum of 3 quarters · filed 2021-03-01 | $156.76M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||||
| 2018-12-31 | $52.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $85.67M derived: sum of 2 quarters · filed 2021-03-01 | $124.37M derived: sum of 3 quarters · filed 2021-03-01 | $159.39M 10-K · filed 2021-03-01 | ||||||||||||||
| 2018-09-30 | $33.40M 10-Q · filed 2019-11-12 | $72.10M derived: sum of 2 quarters · filed 2019-11-12 | $107.11M 10-Q · filed 2019-11-12 | $133.11M derived: sum of 4 quarters · filed 2020-03-02 | ||||||||||||||
| 2018-06-30 | $38.70M 10-Q · filed 2019-08-09 | $73.72M 10-Q · filed 2019-08-09 | $99.71M derived: sum of 3 quarters · filed 2020-03-02 | $126.86M derived: sum of 4 quarters · filed 2020-03-02 | ||||||||||||||
| 2018-03-31 | $35.02M 10-Q · filed 2019-05-10 | $61.01M derived: sum of 2 quarters · filed 2020-03-02 | $88.16M derived: sum of 3 quarters · filed 2020-03-02 | $114.87M derived: sum of 4 quarters · filed 2020-03-02 | ||||||||||||||
| 2017-12-31 | $26.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $53.15M derived: sum of 2 quarters · filed 2020-03-02 | $79.85M derived: sum of 3 quarters · filed 2020-03-02 | $102.53M 10-K · filed 2020-03-02 | $102.53M 10-K · filed 2018-03-15 | |||||||||||||
| 2017-09-30 | $27.15M 10-Q · filed 2018-11-09 | $27.15M 10-Q · filed 2017-11-09 | $53.85M derived: sum of 2 quarters · filed 2018-11-09 | $76.54M 10-Q · filed 2018-11-09 | $76.54M 10-Q · filed 2017-11-09 | $98.82M derived: sum of 4 quarters · filed 2019-03-01 | ||||||||||||
| 2017-06-30 | $26.71M 10-Q · filed 2018-08-09 | $26.71M 10-Q · filed 2017-08-09 | $49.39M 10-Q · filed 2018-08-09 | $49.39M 10-Q · filed 2017-08-09 | $71.67M derived: sum of 3 quarters · filed 2019-03-01 | $93.47M derived: sum of 4 quarters · filed 2019-03-01 | ||||||||||||
| 2017-03-31 | $22.68M 10-Q · filed 2018-05-10 | $22.68M 10-Q · filed 2017-05-10 | $44.97M derived: sum of 2 quarters · filed 2019-03-01 | $66.76M derived: sum of 3 quarters · filed 2019-03-01 | $80.30M derived: sum of 4 quarters · filed 2019-03-01 | |||||||||||||
| 2016-12-31 | $22.28M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $44.08M derived: sum of 2 quarters · filed 2019-03-01 | $57.61M derived: sum of 3 quarters · filed 2019-03-01 | $69.23M 10-K · filed 2019-03-01 | $69.23M 10-K · filed 2017-03-16 | |||||||||||||
| 2016-09-30 | $21.80M 10-Q · filed 2017-11-09 | $35.33M derived: sum of 2 quarters · filed 2017-11-09 | $46.95M 10-Q · filed 2017-11-09 | $62.20M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||||||
| 2016-06-30 | $13.53M 10-Q · filed 2017-08-09 | $25.15M 10-Q · filed 2017-08-09 | $40.41M derived: sum of 3 quarters · filed 2018-03-15 | $51.98M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||||||
| 2016-03-31 | $11.62M 10-Q · filed 2017-05-10 | $26.87M derived: sum of 2 quarters · filed 2018-03-15 | $38.45M derived: sum of 3 quarters · filed 2018-03-15 | $49.71M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||||||
| 2015-12-31 | $15.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $26.83M derived: sum of 2 quarters · filed 2018-03-15 | $38.09M derived: sum of 3 quarters · filed 2018-03-15 | $47.71M 10-K · filed 2018-03-15 | ||||||||||||||
| 2015-09-30 | $11.57M 10-Q · filed 2016-11-09 | $22.84M derived: sum of 2 quarters · filed 2016-11-09 | $32.45M 10-Q · filed 2016-11-09 | $47.59M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2015-06-30 | $11.26M 10-Q · filed 2016-08-09 | $20.88M 10-Q · filed 2016-08-09 | $36.02M derived: sum of 3 quarters · filed 2017-03-16 | $49.71M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2015-03-31 | $9.62M 10-Q · filed 2016-05-10 | $24.75M derived: sum of 2 quarters · filed 2017-03-16 | $38.45M derived: sum of 3 quarters · filed 2017-03-16 | $45.29M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2014-12-31 | $15.14M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $28.83M derived: sum of 2 quarters · filed 2017-03-16 | $35.68M derived: sum of 3 quarters · filed 2017-03-16 | $40.09M 10-K · filed 2017-03-16 | ||||||||||||||
| 2014-09-30 | $13.69M 10-Q · filed 2015-11-09 | $20.54M derived: sum of 2 quarters · filed 2015-11-09 | $24.95M 10-Q · filed 2015-11-09 | $28.71M derived: sum of 4 quarters · filed 2016-03-15 | ||||||||||||||
| 2014-06-30 | $6.85M 10-Q · filed 2015-08-10 | $11.26M 10-Q · filed 2015-08-10 | $15.01M derived: sum of 3 quarters · filed 2016-03-15 | $18.32M derived: sum of 4 quarters · filed 2016-03-15 | ||||||||||||||
| 2014-03-31 | $4.41M 10-Q · filed 2015-05-11 | $8.17M derived: sum of 2 quarters · filed 2016-03-15 | $11.48M derived: sum of 3 quarters · filed 2016-03-15 | $16.50M derived: sum of 4 quarters · filed 2016-03-15 | $39.43M 10-Q · filed 2014-05-14 | |||||||||||||
| 2013-12-31 | $3.76M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $7.07M derived: sum of 2 quarters · filed 2016-03-15 | $12.09M derived: sum of 3 quarters · filed 2016-03-15 | $13.66M 10-K · filed 2016-03-15 | $35.02M 10-K · filed 2014-03-07 | |||||||||||||
| 2013-09-30 | $3.31M 10-Q · filed 2014-11-14 | $8.34M derived: sum of 2 quarters · filed 2014-11-14 | $9.91M 10-Q · filed 2014-11-14 | $10.99M derived: sum of 4 quarters · filed 2014-11-14 | $31.26M 10-Q · filed 2013-11-14 | |||||||||||||
| 2013-06-30 | $5.03M 10-Q · filed 2014-07-24 | $6.60M 10-Q · filed 2014-07-24 | $7.68M derived: sum of 3 quarters · filed 2014-07-24 | $9.24M derived: sum of 4 quarters · filed 2014-07-24 | $27.95M 10-Q · filed 2013-08-09 | |||||||||||||
| 2013-03-31 | $1.57M 10-Q · filed 2014-05-14 | $2.65M derived: sum of 2 quarters · filed 2014-05-14 | $4.21M derived: sum of 3 quarters · filed 2014-05-14 | $5.86M derived: sum of 4 quarters · filed 2014-05-14 | $22.93M 10-Q · filed 2013-05-14 | |||||||||||||
| 2012-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $2.64M derived: sum of 2 quarters · filed 2014-03-07 | $4.29M derived: sum of 3 quarters · filed 2014-03-07 | $21.03M 10-K · filed 2014-03-07 | $21.36M 10-K · filed 2013-03-21 | |||||||||||||
| 2012-09-30 | $1.56M 10-Q · filed 2013-11-14 | $3.21M derived: sum of 2 quarters · filed 2013-11-14 | $19.95M 10-Q · filed 2013-11-14 | $19.96M derived: sum of 4 quarters · filed 2013-11-14 | $20.28M 10-Q · filed 2012-11-14 | |||||||||||||
| 2012-06-30 | $1.65M 10-Q · filed 2013-08-09 | $18.39M 10-Q · filed 2013-08-09 | $18.40M derived: sum of 3 quarters · filed 2013-08-09 | $18.42M derived: sum of 4 quarters · filed 2013-08-09 | $18.71M 10-Q/A · filed 2012-09-07 | |||||||||||||
| 2012-03-31 | $16.74M 10-Q · filed 2013-05-14 | $16.76M derived: sum of 2 quarters · filed 2013-05-14 | $16.77M derived: sum of 3 quarters · filed 2013-05-14 | $17.07M 10-Q · filed 2012-05-14 | ||||||||||||||
| 2011-12-31 | $14.34K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $30.28K derived: sum of 2 quarters · filed 2013-03-21 | $327.28K derived: sum of 3 quarters · filed 2013-03-21 | $327.28K 10-K · filed 2013-03-21 | ||||||||||||||
| 2011-09-30 | $15.94K 10-Q · filed 2012-11-14 | $95.90K 10-Q · filed 2011-11-14 | $312.94K derived: sum of 2 quarters · filed 2012-11-14 | $312.94K 10-Q · filed 2012-11-14 | $541.29K 10-Q · filed 2011-11-14 | $29.37M 10-Q · filed 2011-11-14 | ||||||||||||
| 2011-06-30 | $297.00K 10-Q/A · filed 2012-09-07 | $90.22K 10-Q/A · filed 2011-09-14 | $297.00K 10-Q/A · filed 2012-09-07 | $445.39K 10-Q/A · filed 2011-09-14 | $29.27M 10-Q/A · filed 2011-09-14 | |||||||||||||
| 2010-09-30 | $236.73K 10-Q · filed 2011-11-14 | $287.73K derived: sum of 2 quarters · filed 2011-11-14 | $305.50K 10-Q · filed 2011-11-14 | |||||||||||||||
| 2010-06-30 | $51.00K 10-Q/A · filed 2011-09-14 | $68.77K 10-Q/A · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |